|
|
||||||||
From the Department of Ophthalmology, Johns Hopkins School of Medicine, Baltimore, Maryland.
PURPOSE. Older drivers may place restrictions on their driving by reducing their mileage and avoiding high-risk driving situations in an effort to improve safety. This project identifies what types of visual function loss are associated with subsequent driving modifications.
METHODS. Data were used from the baseline and 2-year follow-up rounds of the Salisbury Eye Evaluation project, a cohort study of 2520 older adults. Measures of visual function tested were visual acuity, contrast sensitivity, visual fields, and glare sensitivity. Driving information was self-reported. Among drivers at baseline who continued to drive at follow-up, multiple logistic regression was used to estimate the odds of incident driving modification by visual function status.
RESULTS. Worse baseline scores in acuity, contrast sensitivity, and central and lower peripheral visual fields were individually associated with an increased odds of reduced mileage 2 years later (linear trend P < 0.05). Worse baseline scores in contrast sensitivity and central and lower peripheral visual fields were individually associated with a greater odds of cessation of night driving 2 years later, whereas worse baseline acuity scores were associated with an increased odds of cessation of driving in an unfamiliar areas 2 years later (linear trend P < 0.05).
CONCLUSIONS. Older drivers with worse visual function were more likely to modify their driving by reducing mileage and avoiding high-risk driving situations. Furthermore, these modifications to driving differed depending on what type of visual function was affected.
This article has been cited by other articles:
![]() |
A. Kotecha, A. Spratt, and A. Viswanathan Visual function and fitness to drive Br. Med. Bull., August 20, 2008; (2008) ldn028v1. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. A. Haymes, R. P. LeBlanc, M. T. Nicolela, L. A. Chiasson, and B. C. Chauhan Glaucoma and On-Road Driving Performance Invest. Ophthalmol. Vis. Sci., July 1, 2008; 49(7): 3035 - 3041. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. J. Balcer, S. L. Galetta, P. A. Calabresi, C. Confavreux, G. Giovannoni, E. Havrdova, M. Hutchinson, L. Kappos, F. D. Lublin, D. H. Miller, et al. Natalizumab reduces visual loss in patients with relapsing multiple sclerosis Neurology, April 17, 2007; 68(16): 1299 - 1304. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. S. Rubin, E. S. W. Ng, K. Bandeen-Roche, P. M. Keyl, E. E. Freeman, S. K. West, and the SEE Project Team A Prospective, Population-Based Study of the Role of Visual Impairment in Motor Vehicle Crashes among Older Drivers: The SEE Study Invest. Ophthalmol. Vis. Sci., April 1, 2007; 48(4): 1483 - 1491. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |